Direkt zum Inhalt

Owner only: item control page
d'Amore, Francesco ; Leppä, Sirpa ; da Silva, Maria Gomes ; Relander, Thomas ; De Nully Brown, Peter ; Weidmann, Eckhart ; Lauritzsen, Grete Fossum ; Pezzutto, Antonio ; Van Hoof, Achiel ; van Gelder, Michel ; Doorduijn, Jeanette K ; Wu, Ka Lung ; Kluin-Nelemans, J.C. ; Lugtenburg, P.J. ; Jankovska, Milada ; Merup, Mats ; Fagerli, Unn-Merete ; Walewski, Jan ; Hagberg, Hans ; Mariz, Jose Mario ; Hansen, Per Boye ; Nösslinger, Thomas ; Janssens, Ann ; Brandefors, Lena ; Demuynck, Hilde ; Schaafsma, Martyn Ronald ; Christiansen, Ilse ; Salek, David ; Jyrkkiö, Sirkku ; Prochazka, Vit ; Zijlstra, Josee ; Böhmer, L. ; Greil, Richard ; Stevens, Wendy ; Fijnheer, Rob ; van Marwijk Kooy, Marinus ; Grube, Matthias ; Hopfinger, Georg ; Van den Neste, Eric ; Jantunen, Esa ; Trümper, Lorenz ; Wulf, Gerald ; Altmann, Bettina ; Ziepert, Marita ; Loeffler, Markus ; Toldbod, Helle

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

d'Amore, Francesco, Leppä, Sirpa, da Silva, Maria Gomes, Relander, Thomas, De Nully Brown, Peter, Weidmann, Eckhart, Lauritzsen, Grete Fossum, Pezzutto, Antonio, Van Hoof, Achiel, van Gelder, Michel, Doorduijn, Jeanette K, Wu, Ka Lung, Kluin-Nelemans, J.C., Lugtenburg, P.J., Jankovska, Milada, Merup, Mats, Fagerli, Unn-Merete, Walewski, Jan, Hagberg, Hans, Mariz, Jose Mario, Hansen, Per Boye, Nösslinger, Thomas, Janssens, Ann, Brandefors, Lena, Demuynck, Hilde, Schaafsma, Martyn Ronald, Christiansen, Ilse, Salek, David, Jyrkkiö, Sirkku, Prochazka, Vit, Zijlstra, Josee, Böhmer, L., Greil, Richard , Stevens, Wendy, Fijnheer, Rob, van Marwijk Kooy, Marinus, Grube, Matthias, Hopfinger, Georg, Van den Neste, Eric, Jantunen, Esa, Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus and Toldbod, Helle (2012) First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood 120 (21), p. 57.

Date of publication of this fulltext: 19 Dec 2024 09:34
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBlood
Publisher:AMER SOC HEMATOLOGY
Place of Publication:WASHINGTON
Volume:120
Number of Issue or Book Chapter:21
Page Range:p. 57
Date2012
InstitutionsMedicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Identification Number
ValueType
10.1182/blood.V120.21.57.57DOI
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID63153

Export bibliographical data

Owner only: item control page

nach oben